The fourth episode of “Immuno Oncology Talks”, Professor Marjolein van Egmond from the Amsterdam University Medical Center, in the Netherlands, will shed light on neutrophils as effector cells in cancer therapy. Professor Marjolein van Egmond specializes in the innate immune system and is focusing on elucidating the therapeutic potential of neutrophils in cancer, with a specific interest in IgA and bispecific antibodies to activate the neutrophils.  For more information please visit: <a href='https://www.sanofi.se/sv/podcast/targeting-neutrophils-effector-cells-cancer-therapy'>Sanofi Immuno Oncology Talks website</a> MAT-BE-2200978 (ver. 1.0) 12 2022

Adoptive therapy with engineered T cell receptors

The Immuno Oncology Talks aims to shed light on cutting edge science that is evolving with new immunological therapeutic approaches for the treatment of cancers. The podcasts consist of discussions with leading experts and are intended for anyone that would like to broaden their knowledge of what is happening in this rapidly expanding field. MAT-BE-2200553 (ver 1.0) 09 2022.